GTBP·Nasdaq·US
GT Biopharma
GT Biopharma is a clinical-stage immuno-oncology company developing TriKE-based therapeutic candidates that harness natural killer cells to target cancers. The company is focused on advancing its pipeline through clinical development and potential future commercialization or partnering.
Thematic Position
Relationship Groups
Relationship details are part of the Pro plan.